Lisa K. Kunkle - Nov 15, 2021 Form 4 Insider Report for AVIENT CORP (AVNT)

Role
SVP Gnrl Counsel & Secretary
Signature
/s/ Lisa K. Kunkle
Stock symbol
AVNT
Transactions as of
Nov 15, 2021
Transactions value $
-$1,140,024
Form type
4
Date filed
11/17/2021, 03:30 PM
Next filing
Feb 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNT Common Stock Options Exercise $240K +10.4K +14.94% $23.08 80K Nov 15, 2021 Direct
transaction AVNT Common Stock Disposed to Issuer -$357K -5.98K -7.48% $59.58 74K Nov 15, 2021 Direct
transaction AVNT Common Stock Options Exercise $249K +7.1K +9.59% $35.07 81.1K Nov 15, 2021 Direct
transaction AVNT Common Stock Disposed to Issuer -$326K -5.48K -6.75% $59.58 75.7K Nov 15, 2021 Direct
transaction AVNT Common Stock Options Exercise $325K +8.5K +11.24% $38.27 84.2K Nov 15, 2021 Direct
transaction AVNT Common Stock Disposed to Issuer -$406K -6.81K -8.09% $59.58 77.3K Nov 15, 2021 Direct
transaction AVNT Common Stock Options Exercise $287K +11.5K +14.87% $24.98 88.8K Nov 15, 2021 Direct
transaction AVNT Common Stock Disposed to Issuer -$464K -7.78K -8.76% $59.58 81.1K Nov 15, 2021 Direct
transaction AVNT Common Stock Sale -$689K -11.4K -14.12% $60.22 69.6K Nov 16, 2021 Direct F1
holding AVNT Common Stock 1.99K Nov 15, 2021 Savings Plan Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVNT Stock Appreciation Rights Options Exercise $0 -10.4K -100% $0.00* 0 Nov 15, 2021 Common Stock 10.4K $23.08 Direct F3
transaction AVNT Stock Appreciation Rights Options Exercise $0 -7.1K -100% $0.00* 0 Nov 15, 2021 Common Stock 7.1K $35.07 Direct F4
transaction AVNT Stock Appreciation Rights Options Exercise $0 -8.5K -100% $0.00* 0 Nov 15, 2021 Common Stock 8.5K $38.27 Direct F5
transaction AVNT Stock Appreciation Rights Options Exercise $0 -11.5K -100% $0.00* 0 Nov 15, 2021 Common Stock 11.5K $24.98 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale price is a weighted average for the sale transactions. The sales prices range from a low of $59.44 per share to a high of $60.84. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, Avient Corporation or a security holder of Avient Corporation.
F2 The information in this report is based on a Avient Retirement Savings Plan statement as of November 15, 2021.
F3 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $23.08 per share and no more than one-third of the grant can vest per year during the first three years.
F4 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $35.07 per share and no more than one-third of the grant can vest per year during the first three years.
F5 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $38.27 per share and no more than one-third of the grant can vest per year during the first three years.
F6 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $24.98 per share and no more than one-third of the grant can vest per year during the first three years.